3 Japanese Dividend Stocks for Reliable Income in 2026
Food prices tracked by the FAO are at multiyear highs, which keeps inflation worries alive for many households and central banks. In that setting, steady dividend income looks more attractive than ever. High-yielding companies that keep paying and aim to grow their dividends can help smooth the bumps of market swings. This article looks at three stocks from the Dividend Powerhouses screener that fit that brief.
The three featured stocks are just a starting sample from this idea, and the full screen surfaced 445 more companies with equally compelling dividend stories that this article does not cover. To go straight to the source and identify, compare, and analyze your own high-conviction income opportunities, head into the Dividend Powerhouses (3%+ Yield) screener.
Canon (TSE:7751)
Overview: Canon is a Japan headquartered technology company that designs, manufactures, and services a wide range of printers, cameras, medical imaging systems, and industrial equipment sold globally under the Canon brand.
Operations: Canon generates most of its revenue from Printing at about ¥2,513b, with Imaging at about ¥1,135b, Medical at about ¥579b, Industrial at about ¥347b, and additional contributions from other and corporate operations.
Market Cap: ¥3,936.7b
Income focused investors may want to look closer at Canon because it combines a broad hardware and solutions portfolio with improving profitability, including a net margin of 7.4% that is described as high quality earnings and earnings growth of 109.1% over the past year. The stock trades on a P/E of 11.3x compared with an Asian tech industry average of 21.9x and is flagged as trading well below one estimate of fair value, which can be appealing for dividend hunters. At the same time, the company has an unstable dividend track record and relatively low forecast revenue and earnings growth, so the yield story comes with trade offs that deserve a deeper look.
Canon’s low P/E and high quality earnings profile suggest the market may be missing part of the story, especially for income seekers weighing trade offs. Get the full picture with the 4 key rewards and 1 important warning sign
Build your own dividend and value shortlist around Canon
Canon and the two other dividend stocks in this article all came from a single screener, but the real edge is in setting your own rules. Use our flexible Screener to blend filters like valuation, earnings quality, balance sheet strength, risks, and dividends, or jump straight into our curated Investing Ideas for ready made starting points.
Tokio Marine Holdings (TSE:8766)
Overview: Tokio Marine Holdings is a major Japanese insurer that offers a wide range of non life and life insurance products, reinsurance, and related financial and risk management services for individuals, companies, and institutions in Japan, the United States, and other international markets.
Operations: Tokio Marine Holdings generates most of its revenue from Overseas Insurance Business at about ¥5,188.7b and Domestic Property and Casualty Insurance at about ¥3,136.4b, with smaller contributions from Domestic Life Insurance and Solution and Other Business.
Market Cap: ¥14,700.0b
Income investors may track Tokio Marine Holdings because it combines a 3.09% dividend yield with a long established global insurance franchise and an active share buyback program that has already retired over 38.6 million shares this year. Management is reshaping the group through the Re New initiative, equity divestments, and a shift toward higher value solution businesses such as disaster resilience, with the stated aim of lifting efficiency and returns. At the same time, recent margin compression, higher funding risk from full reliance on external borrowing, and exposure to more volatile international assets mean this is not a simple income story and call for closer scrutiny of how the transformation progresses over the next few years.
Tokio Marine’s Re New shift, buybacks, and overseas mix could be reshaping its income profile in ways the headline 3.09% yield does not fully show. See how the story fits together in the 3 key rewards and 1 important warning sign
Daiichi Sankyo Company (TSE:4568)
Overview: Daiichi Sankyo Company is a Japan headquartered pharmaceutical group focused on prescription drugs, with a strong presence in oncology, cardiovascular and metabolic disease, pain, neurology, vaccines, and other specialty areas across Japan and international markets.
Operations: Daiichi Sankyo Company generates its revenue almost entirely from its Pharmaceutical Operation, which produced about ¥2,223.2b.
Market Cap: ¥5,009.7b
Daiichi Sankyo Company is drawing attention because its oncology portfolio, anchored by ENHERTU and Datroway, is gaining fresh approvals in the U.S., EU, and China. Q1 FY2026 results and upgraded guidance highlight how new indications are feeding into stronger revenue. The company also has a deep pipeline in antibody drug conjugates and partnerships with global pharma heavyweights, which adds breadth to the story. At the same time, earnings are heavily tied to a few blockbuster drugs, margins have softened from last year, and free cash flow does not fully cover the 3.63% dividend. For income investors, the mix of growth, concentration risk, and dividend coverage concerns makes this a business that rewards closer study rather than quick conclusions.
Daiichi Sankyo’s accelerating oncology story and 3.63% dividend are only half the picture. Learn how blockbuster reliance, margin pressure, and cash coverage fit together in the analysis report for Daiichi Sankyo Company
Seeking Alternatives Before The Window Closes
Fresh ideas can move quickly. Some stocks are already building breakout momentum while others are still under the radar for now. Do not get caught reacting late, consider acting sooner rather than later.
- Spot early movers in resilient sectors and explore a curated pool of 56 resilient stocks with low risk scores before the crowd starts focusing on the same stable opportunities.
- Follow structural themes in critical materials and review a focused group drawn from the 28 best rare earth metal stocks while prices and attention have not fully aligned.
- Monitor potential breakouts in essential infrastructure and examine the hand picked universe inside the 37 power grid technology and infrastructure stocks while these assets are still less widely followed.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com